Risk of Arrhythmia among New Users of Hydroxychloroquine: Reply to the Comment on the article by Hoque, et al.
Wiley Online Library » Arthritis & Rheumatology
by M Rashedul Hoque, Diane Lacaille, John M Esdaile, Hui Xie, J Antonio Aviña‐Zubieta
5d ago
Arthritis &Rheumatology, Accepted Article ..read more
Visit website
Risk of Arrhythmia Among New Users of Hydroxychloroquine: Comment on the article by Hoque, et al
Wiley Online Library » Arthritis & Rheumatology
by Julianna Desmarais, James T Rosenbaum, Mark Link, Richard Kovacs
5d ago
Arthritis &Rheumatology, Accepted Article ..read more
Visit website
Shared and Distinctive Transcriptomic and Proteomic Pathways in Adult and Juvenile Dermatomyositis
Wiley Online Library » Arthritis & Rheumatology
by James Ward, Mythri Ambatipudi, Terrance P O'Hanlon, Michael A. Smith, Melissa Los Reyes, Adam Schiffenbauer, Saifur Rahman, Kamelia Zerrouki, Frederick W. Miller, Miguel A. Sanjuan, Jian‐Liang Li, Kerry A. Casey, Lisa G. Rider
5d ago
Objective Transcript and protein expression were interrogated to examine gene locus and pathway regulation in the peripheral blood of active adult dermatomyositis (DM) and juvenile DM (JDM) patients receiving immunosuppressive therapies. Methods Expression data from 14 DM and 12 JDM patients were compared to matched healthy controls. Regulatory effects at the transcript and protein level were analyzed by multi-enrichment analysis for assessment of affected pathways within DM and JDM. Results Expression of 1,124 gene loci were significantly altered at the transcript or protein levels across DM ..read more
Visit website
Baricitinib improves bone properties and biomechanics in patients with rheumatoid arthritis – results of the prospective interventional BARE BONE trial
Wiley Online Library » Arthritis & Rheumatology
by David Simon, Ioanna Minopoulou, Stephan Kemenes, Sara Bayat, Koray Tascilar, Melek Yalcin Mutlu, Larissa Valor‐Méndez, Gerhard Krönke, Axel J Hueber, Georg Schett, Arnd Kleyer
5d ago
Objectives Rheumatoid arthritis (RA) is characterized by erosive joint damage, deterioration of bone mass and biomechanics. Preclinical evidence suggests a beneficial effect of Janus Kinase inhibition (JAKi) on bone properties, but clinical data are scarce to date. In this study we evaluated the effect of JAKi through baricitinib (BARI) on (i) volumetric bone mineral density (vBMD), bone microstructure, biomechanics, erosion repair and (ii) synovial inflammation in RA patients. Methods Prospective, single-arm, interventional, open-label, single-center phase 4 study in RA patients with patholog ..read more
Visit website
Expert Perspective: Challenges in Sjögren's Disease
Wiley Online Library » Arthritis & Rheumatology
by Gaetane Nocturne, Xavier Mariette
5d ago
The management of Sjogren's disease is challenging because of several factors. Indeed, the presentations are heterogeneous, and one must be able to identify prognostic markers to adapt the follow-up. In addition, there is no validated treatment. Nevertheless, international experts have been working for several years to establish recommendations to guide management. However, research in this field is extremely active, and we can hope for the development of effective treatments for our patients in the near future. This article is protected by copyright. All rights reserved ..read more
Visit website
2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis
Wiley Online Library » Arthritis & Rheumatology
by Bryant R. England, Benjamin J. Smith, Nancy A. Baker, Jennifer L. Barton, Carol A. Oatis, Gordon Guyatt, Allen Anandarajah, Kristine Carandang, Karmela Kim Chan, Deb Constien, Eileen Davidson, Carole V. Dodge, Anita Bemis‐Dougherty, Sotiria Everett, Nadine Fisher, Liana Fraenkel, Susan M. Goodman, Janet Lewis, Victoria Menzies, Larry W. Moreland, Iris Navarro‐Millan, Sarah Patterson, Lawrence “Rick” Phillips, Neha Shah, Namrata Singh, Daniel White, Rawan AlHeresh, Kamil E. Barbour, Thomas Bye, Dana Guglielmo, Rebecca Haberman, Tate Johnson, Anatole Kleiner, Chris Y. Lane, Linda C. Li, Hiral Master, Daniel Pinto, Janet L. Poole, Kimberly Steinbarger, Daniel Sztubinski, Louise Thoma, Vlad Tsaltskan, Marat Turgunbaev, Courtney Wells, Amy S. Turner, Jonathan R. Treadwell
5d ago
Objective To develop initial American College of Rheumatology (ACR) guidelines on the use of exercise, rehabilitation, diet, and additional interventions in conjunction with disease-modifying antirheumatic drugs (DMARDs) as part of an integrative management approach for people with rheumatoid arthritis (RA). Methods An interprofessional guideline development group constructed clinically relevant Population, Intervention, Comparator, and Outcome (PICO) questions. A literature review team then completed a systematic literature review and applied the Grading of Recommendations Assessment, Develop ..read more
Visit website
Alteration of gut microbiota in high‐risk individuals for rheumatoid arthritis is associated with disturbed metabolome and initiates arthritis by triggering mucosal immunity imbalance
Wiley Online Library » Arthritis & Rheumatology
by Yubin Luo, Yanli Tong, Liang Wu, Haitao Niu, Yanhong Li, Lin Chong Su, Yuxi Wu, Aline Bozec, Mario M. Zaiss, Pingying Qing, Hua Zhao, Chunyu Tan, Qiuping Zhang, Yi Zhao, Huairong Tang, Yi Liu
1w ago
Objective We aimed to decipher the gut microbiome (GM) and serum metabolic characteristic of individuals at high risk for rheumatoid arthritis (RA) and to investigate the causative effect of GM on the mucosal immune system and its involvement in the pathogenesis of arthritis. Design Fecal samples were collected from 38 healthy individuals (HCs) and 53 high-risk RA individuals with anti-citrullinated protein antibody (ACPA)-positivity (PreRA), 12 of 53 PreRA developed RA within 5 years of follow-up. The differences in intestinal microbial composition between the HC and PreRA individuals or amon ..read more
Visit website
Whole‐Exome Sequencing Reveals Distinct Genetic Profiles of Palindromic Rheumatism
Wiley Online Library » Arthritis & Rheumatology
by Chenxiang Zheng, Fan Wang, Yue Sun, Zhuochao Zhou, Yijun You, Dongyi He, Xiaoxia Zhu, Lindi Jiang, Cui Lu, Lijun Wu, Hongzhi Wang, Hanying Mei, Ting Zeng, Hui Zheng, Jialing Teng, Honglei Liu, Xiaobing Cheng, Yutong Su, Hui Shi, Qiongyi Hu, Xueming Jian, Aamir Fahira, Qiangzhen Yang, Ke Wang, Yanqin Wen, Zhuo Wang, Jinyan Huang, Chengde Yang, Yongyong Shi, Junna Ye
1w ago
Objective Previous studies underline the genetic susceptibility in the pathogenesis of Palindromic Rheumatism (PR), but the known PR loci only explain partially the disease's genetic background. We aim to genetically identify PR by whole exome sequencing (WES). Methods This multi-center prospective study was conducted in ten Chinese specialized rheumatology centers between September 2015 and January 2020. WES was performed in a PR cohort (185 PR cases and 272 healthy controls). PR patients were divided in to ACPA- PR and ACPA+ PR subgroups according to ACPA titer (cut-off value: 20UI/I). Whole ..read more
Visit website
The clinical impact of electronic patient‐reported outcome measures in the remote monitoring of inflammatory arthritis: a systematic review and meta‐analysis
Wiley Online Library » Arthritis & Rheumatology
by Nikita Arumalla, Chun K. D. Chan, Mark Gibson, Yik L. Man, Maryam A. Adas, Sam Norton, James B. Galloway, Toby Garrood
1w ago
Objective The inflammatory arthritides (IA) make up a significant proportion of conditions followed-up in rheumatology clinics. These patients require regular monitoring, but this is increasingly difficult with rising patient numbers and demand on clinics. Our objective is to evaluate the clinical impact of electronic Patient Reported Outcome Measures (ePROMs) as a digital remote monitoring intervention on disease activity, treatment decisions and healthcare resource use in patients with IA. Methods Five databases (MEDLINE, Embase, PubMed, Cochrane Library and Web of Science) were searched, wi ..read more
Visit website
Efficacy and Safety of Tyrosine Kinase 2/Janus Kinase 1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial
Wiley Online Library » Arthritis & Rheumatology
by Philip Mease, Philip Helliwell, Paula Silwinska‐Stanczyk, Malgorzata Miakisz, Andrew Ostor, Elena Peeva, Michael S. Vincent, Qiankun Sun, Vanja Sikirica, Randall Winnette, Ruolun Qiu, Gang Li, Gang Feng, Jean S. Beebe, David A. Martin
2w ago
Objective Brepocitinib is a tyrosine kinase 2/Janus kinase 1 inhibitor in development for treatment of several immunological diseases. Efficacy and safety of oral brepocitinib were assessed in participants with moderately-to-severely active psoriatic arthritis (PsA) for up to 52 weeks. Methods This placebo-controlled, dose-ranging, phase IIb study randomized participants to brepocitinib 10 mg once daily (QD), 30 mg QD, 60 mg QD, or placebo, advancing to brepocitinib 30 or 60 mg QD at week 16. The primary endpoint was American College of Rheumatology (ACR)20 response rate at week 16. Secondary ..read more
Visit website

Follow Wiley Online Library » Arthritis & Rheumatology on Feedspot

Continue with Google
Continue with Apple
OR